DIRECTED EVOLUTION OF ENZYMES USING OPTICAL SORTING

Information

  • Research Project
  • 2024585
  • ApplicationId
    2024585
  • Core Project Number
    R43GM056042
  • Full Project Number
    1R43GM056042-01
  • Serial Number
    56042
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/1997 - 27 years ago
  • Project End Date
    2/28/1998 - 26 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1997 - 27 years ago
  • Budget End Date
    2/28/1998 - 26 years ago
  • Fiscal Year
    1997
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/31/1997 - 27 years ago
Organizations

DIRECTED EVOLUTION OF ENZYMES USING OPTICAL SORTING

DESCRIPTION: (Adapted from the Applicant's Abstract): Noninvasive methodologies for assaying enzymatic activity within cells are currently unable to differentiate between increased levels of protein expression and improved catalytic activity. In protein engineering, the former category mutants are often considered false positives and are usually the result of 'promoter up' mutations, rather than the desired physicochemical effect of improving enzyme efficiency. It is proposed to use the fluorescence signal from the green fluorescent protein (GFP) in fusion with enzymes to normalize for expression levels in single cells assayed by noninvasive optical techniques. In model studies, E-coli strains expressing a GFP-glucosidase fusion protein will be screened by quantitative imaging techniques. The chromogenic signal resulting from enzyme-catalyzed turnover of the substrate X-glu will be normalized by the fluorescence signal from the co-translated GFP tag, thus giving a measure of the specific activity of the enzyme. This optical screening procedure will be validated by constructing a series of GFP-glucosidase fusions in which the glucosidase gene product is either wild-type or impaired due to mutations affecting the rate of substrate turnover. Optical parameters (absorbance combined with fluorescence) will be measured on a cell sorter for selecting repetitively mutagenized bacteria to isolate enzymes with novel catalytic activities from very large mutagenized populations (>106 clones).

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG2
  • Study Section Name
  • Organization Name
    KAIROS SCIENTIFIC, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92121
  • Organization District
    UNITED STATES